Related Experiment Video

Updated: Aug 15, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
10:22

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum

Published on: December 4, 2015

Molecular pathogenesis of anemia of chronic disease

Tomas Ganz1

  • 1Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA. tganz@mednet.ucla.edu

Pediatric Blood & Cancer
|November 2, 2005
PubMed

Insights

Anemia of chronic disease involves low iron and is caused by inflammatory cytokines like IL-6. These cytokines increase hepcidin, blocking iron release and leading to anemia in chronic conditions.

Area of Science:

  • Hematology
  • Immunology
  • Pathophysiology

Background:

  • Anemia of chronic disease (ACD) affects patients with chronic infections, inflammatory diseases, and malignancies.
  • ACD is characterized by low serum iron, low to normal transferrin, and high to normal serum ferritin.
  • The underlying mechanisms involve inflammatory cytokines disrupting iron homeostasis.

Purpose of the Study:

  • To elucidate the role of inflammatory cytokines in the pathogenesis of anemia of chronic disease.
  • To understand the mechanism by which hepcidin regulates iron levels in ACD.
  • To explain the iron-deprivation of erythrocytes in ACD.

Main Methods:

  • Review of literature on anemia of chronic disease.
  • Analysis of the role of interleukin-6 (IL-6) in hepcidin production.
  • Examination of hepcidin's effect on iron transport in macrophages, hepatocytes, and enterocytes.

Main Results:

  • Increased inflammatory cytokines, particularly IL-6, stimulate hepatocytes to produce more hepcidin.
  • Hepcidin effectively blocks iron release from macrophages, hepatocytes, and enterocytes.
  • This blockade results in hypoferremia (low serum iron) and iron deficiency for developing red blood cells.

Conclusions:

  • The inflammatory cytokine IL-6 plays a central role in ACD by upregulating hepcidin.
  • Hepcidin-induced iron sequestration is the primary cause of hypoferremia and anemia in chronic inflammatory conditions.
  • Understanding this pathway is crucial for managing anemia in patients with chronic diseases.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation